R. Kip Guy, PhD
Affiliations: | 1998-2005 | Pharmaceutical Chemistry | University of California, San Francisco, San Francisco, CA |
2005-2016 | Chemical Biology and Therapeutics | St Jude Children's Research Hospital, New York, NY, United States | |
2016- | Pharmaceutical Sciences | University of Kentucky, Lexington, KY |
Area:
Medicinal ChemistryWebsite:
http://pharmacy.uky.edu/faculty/rkgu223/Rodney-GuyGoogle:
"R. Kip Guy"Mean distance: 7.34 | S | N | B | C | P |
Parents
Sign in to add mentorK. C. Nicolaou | grad student | 1991-1996 | Scripps Institute |
Michael Stuart Brown | post-doc | 1996-1998 | UT Southwestern |
Joseph L. Goldstein | post-doc | 1996-1998 | UT Southwestern |
Robert J. Fletterick | research scientist | 1998-2014 | UCSF |
Children
Sign in to add traineeCollaborators
Sign in to add collaboratorJoseph DeRisi | collaborator | 1999- | UCSF |
Brenda A. Schulman | collaborator | 2007- | (Cell Biology Tree) |
Robert J. Fletterick | collaborator | 1998-2005 | UCSF |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Eagon S, Hammill JT, Sigal MS, et al. (2020) Synthesis and structure-activity relationship of dual-stage antimalarial pyrazolo[3,4-b]pyridines. Journal of Medicinal Chemistry |
Slavish PJ, Chi L, Yun MK, et al. (2020) Bromodomain-selective BET inhibitors are potent antitumor agents against MYC-driven pediatric cancer. Cancer Research |
Kim HS, Hammill JT, Scott DC, et al. (2019) Discovery of Novel Pyrazolo-Pyridone DCN1 Inhibitors Controlling Cullin Neddylation. Journal of Medicinal Chemistry |
Genthe JR, Min J, Farmer DM, et al. (2019) Ventromorphins: A New Class of Small Molecule Activators of the Canonical BMP Signaling Pathway. Acs Chemical Biology |
Drenberg CD, Shelat A, Dang J, et al. (2019) A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML. Nature Communications. 10: 2189 |
Zhao Y, Cushing PR, Smithson DC, et al. (2018) Correction: Cysteine modification reveals an allosteric inhibitory site on the CAL PDZ domain. Bioscience Reports |
Hammill JT, Scott DC, Min J, et al. (2018) Piperidinyl Ureas Chemically Control Defective in Cullin Neddylation 1 (DCN1)-mediated Cullin Neddylation. Journal of Medicinal Chemistry |
Hammill JT, Bhasin D, Scott DC, et al. (2018) Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-mediated Cullin Neddylation. Journal of Medicinal Chemistry |
Zhao Y, Cushing PR, Smithson DC, et al. (2018) Cysteine modification reveals an allosteric inhibitory site on the CAL PDZ domain. Bioscience Reports |
Nimmervoll B, Boulos N, Bianski BM, et al. (2018) Establishing A Preclinical Multidisciplinary Board for Brain Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |